372 related articles for article (PubMed ID: 15627787)
1. Renal outcome and predictors of clinical renal involvement in patients with silent lupus nephritis.
Wada Y; Ito S; Ueno M; Nakano M; Arakawa M; Gejyo F
Nephron Clin Pract; 2004; 98(4):c105-11. PubMed ID: 15627787
[TBL] [Abstract][Full Text] [Related]
2. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
[TBL] [Abstract][Full Text] [Related]
3. Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus.
Ishizaki J; Saito K; Nawata M; Mizuno Y; Tokunaga M; Sawamukai N; Tamura M; Hirata S; Yamaoka K; Hasegawa H; Tanaka Y
Rheumatology (Oxford); 2015 Mar; 54(3):405-12. PubMed ID: 25183834
[TBL] [Abstract][Full Text] [Related]
4. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
5. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
Matrat A; Veysseyre-Balter C; Trolliet P; Villar E; Dijoud F; Bienvenu J; Fabien N
Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718
[TBL] [Abstract][Full Text] [Related]
8. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
9. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
[TBL] [Abstract][Full Text] [Related]
10. Silent renal disease in systemic lupus erythematosus.
Font J; Torras A; Cervera R; Darnell A; Revert L; Ingelmo M
Clin Nephrol; 1987 Jun; 27(6):283-8. PubMed ID: 3497000
[TBL] [Abstract][Full Text] [Related]
11. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
12. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus.
Linnik MD; Hu JZ; Heilbrunn KR; Strand V; Hurley FL; Joh T;
Arthritis Rheum; 2005 Apr; 52(4):1129-37. PubMed ID: 15818711
[TBL] [Abstract][Full Text] [Related]
13. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
[TBL] [Abstract][Full Text] [Related]
14. Lupus nephritis in children--a review of 167 patients.
Yang LY; Chen WP; Lin CY
Pediatrics; 1994 Sep; 94(3):335-40. PubMed ID: 8065859
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
16. Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus?
Merola JF; Chang CA; Sanchez MR; Prystowsky SD
J Drugs Dermatol; 2011 Dec; 10(12):1413-20. PubMed ID: 22134565
[TBL] [Abstract][Full Text] [Related]
17. Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis.
Spertini F; Leimgruber A; Morel B; Khazaeli MB; Yamamoto K; Dayer JM; Weisbart RH; Lee ML
J Rheumatol; 1999 Dec; 26(12):2602-8. PubMed ID: 10606369
[TBL] [Abstract][Full Text] [Related]
18. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
[TBL] [Abstract][Full Text] [Related]
19. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
20. Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis.
Miguel DF; Terreri MT; Pereira RMR; Bonfá E; Silva CAA; Corrente JE; Magalhaes CS;
Adv Rheumatol; 2020 Feb; 60(1):10. PubMed ID: 32005292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
